Lonza Group AG (LONN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lonza Group AG (LONN) has a cash flow conversion efficiency ratio of 0.085x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF783.00 Million ≈ $989.92 Million USD) by net assets (CHF9.19 Billion ≈ $11.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Lonza Group AG fund operations to measure how many days the company can operate on defensive assets alone.
Lonza Group AG - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Lonza Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lonza Group AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lonza Group AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Advanced Info Service Public Company Limited
BK:ADVANC
|
0.311x |
|
Las Vegas Sands Corp
NYSE:LVS
|
0.623x |
|
KERING.UNSP.ADR 1/10 EO 4
F:PPXB
|
N/A |
|
Kinross Gold Corp
TO:K
|
0.124x |
|
Guotai Junan Securities Co Ltd
SHG:601211
|
0.066x |
|
Gold Fields Limited
F:EDG
|
0.048x |
|
Carnival Corporation
NYSE:CCL
|
0.097x |
|
Halliburton Company
NYSE:HAL
|
0.025x |
Annual Cash Flow Conversion Efficiency for Lonza Group AG (2004–2025)
The table below shows the annual cash flow conversion efficiency of Lonza Group AG from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Lonza Group AG market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF9.19 Billion ≈ $11.61 Billion |
CHF1.17 Billion ≈ $1.48 Billion |
0.127x | -6.23% |
| 2024-12-31 | CHF9.39 Billion ≈ $11.87 Billion |
CHF1.27 Billion ≈ $1.61 Billion |
0.136x | -6.80% |
| 2023-12-31 | CHF9.51 Billion ≈ $12.03 Billion |
CHF1.39 Billion ≈ $1.75 Billion |
0.146x | +52.24% |
| 2022-12-31 | CHF10.66 Billion ≈ $13.48 Billion |
CHF1.02 Billion ≈ $1.29 Billion |
0.096x | -22.80% |
| 2021-12-31 | CHF9.82 Billion ≈ $12.42 Billion |
CHF1.22 Billion ≈ $1.54 Billion |
0.124x | -24.52% |
| 2020-12-31 | CHF6.88 Billion ≈ $8.70 Billion |
CHF1.13 Billion ≈ $1.43 Billion |
0.164x | +9.29% |
| 2019-12-31 | CHF6.57 Billion ≈ $8.30 Billion |
CHF986.00 Million ≈ $1.25 Billion |
0.150x | -12.69% |
| 2018-12-31 | CHF6.29 Billion ≈ $7.95 Billion |
CHF1.08 Billion ≈ $1.37 Billion |
0.172x | +26.43% |
| 2017-12-31 | CHF6.18 Billion ≈ $7.81 Billion |
CHF841.00 Million ≈ $1.06 Billion |
0.136x | -57.39% |
| 2016-12-31 | CHF2.35 Billion ≈ $2.98 Billion |
CHF752.00 Million ≈ $950.73 Million |
0.319x | -8.00% |
| 2015-12-31 | CHF2.13 Billion ≈ $2.70 Billion |
CHF741.00 Million ≈ $936.82 Million |
0.347x | +53.06% |
| 2014-12-31 | CHF2.13 Billion ≈ $2.69 Billion |
CHF483.00 Million ≈ $610.64 Million |
0.227x | -7.65% |
| 2013-12-31 | CHF2.13 Billion ≈ $2.69 Billion |
CHF522.00 Million ≈ $659.95 Million |
0.246x | -16.80% |
| 2012-12-31 | CHF2.41 Billion ≈ $3.04 Billion |
CHF710.00 Million ≈ $897.63 Million |
0.295x | +214.59% |
| 2011-12-31 | CHF2.36 Billion ≈ $2.98 Billion |
CHF221.00 Million ≈ $279.40 Million |
0.094x | -55.40% |
| 2010-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
CHF502.00 Million ≈ $634.66 Million |
0.210x | +19.06% |
| 2009-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
CHF422.00 Million ≈ $533.52 Million |
0.177x | +80.58% |
| 2008-12-31 | CHF1.79 Billion ≈ $2.26 Billion |
CHF175.00 Million ≈ $221.25 Million |
0.098x | -72.54% |
| 2007-12-31 | CHF1.81 Billion ≈ $2.29 Billion |
CHF644.00 Million ≈ $814.19 Million |
0.356x | +34.68% |
| 2006-12-31 | CHF1.61 Billion ≈ $2.03 Billion |
CHF425.00 Million ≈ $537.31 Million |
0.264x | -4.59% |
| 2005-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
CHF413.00 Million ≈ $522.14 Million |
0.277x | +100.10% |
| 2004-12-31 | CHF1.28 Billion ≈ $1.62 Billion |
CHF178.00 Million ≈ $225.04 Million |
0.139x | -- |
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biol… Read more